Pharmaceuticals & life sciences

The environment in which Pharmaceutical and Life Sciences companies operate is increasingly challenging, being driven by a more and more demanding healthcare agenda. The need for innovative, cost effective medicines continues to rise whilst regulators, payers, health care providers and patients are demanding greater value for money, proven effectiveness of products, more transparency and access to information. To meet these demands companies are seeking ways to improve R&D productivity, increase the efficiency of its operations, rationalise spending on sales and marketing and enhance financial performance.

Working closely with our clients, ranging from small entrepreneurial life science companies to large corporations, we aim to create value and optimise companies' strategies by supporting to deliver growth through M&A and increase performance by improving the efficiency of the companies’ key business operations.

Contact us

Andrea Fortuna

Andrea Fortuna

Partner | Health Industries Leader, PwC Italy